Impaired transforming growth factor β signalling in Barrett's carcinogenesis due to frequent SMAD4 inactivation

Gut

Volumn 55, Issue 6, 2006, Pages 764-774

  Onwuegbusi, B A ^a   Aitchison, A ^b   Chin, S F ^b   Kranjac, T ^b   Mills, I ^b   Huang, Y ^a   Lao Sirieix, P ^a   Caldas, C ^b   Fitzgerald, R C ^a  

^a HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; GLUTAMINE; ISOPROTEIN; MESSENGER RNA; MINICHROMOSOME MAINTENANCE PROTEIN 2; PENICILLIN G; PROTEIN P21; SMAD4 PROTEIN; STREPTOMYCIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BARRETT ESOPHAGUS; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME 18; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DOWN REGULATION; DYSPLASIA; ENDOSCOPIC BIOPSY; ESOPHAGUS CARCINOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEFECT; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BASE SEQUENCE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 33646805725     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.076430     Document Type: Article

References (41)

1. Devesa S, Blot W, Jr JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;15:2049-53.
2. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
3. O'Shaughnessy JA, Kelloff GJ, Gordon GB, et al. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development: recommendations of the American Association for Cancer Research Task Force on the treatment and prevention of intraepithelial neoplasia. Clin Cancer Res 2002;8:314-46.
4. Wild CP, Hardie LJ. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer 2003;3:676-84.
5. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001;29:117-29.
6. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998;67:753-91.
7. Duval A, Hamelin R. Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res 2002;62:2447-54.
8. Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-3.
9. Miyaki M, Iijima T, Konishi M, et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 1999;18:3098-103.
10. Blaker H, von Herbay A, Penzel R, et al. Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene. Oncogene 2002;21:158-64.
11. Iwaya T, Maesawa C, Nishizuka S, et al. Infrequent frameshift mutations of polynucleotide repeats in multiple primary cancers affecting the esophagus and other organs. Genes Chromosomes Cancer 1998;23:317-22.
12. Souza RF, Garrigue-Antar L, Lei J, et al. Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasms. Hum Cell 1996;9:229-36.
13. Muzeau F, Flejou JF, Belghiti J, et al. Infrequent microsatellite instability in oesophageal cancers. Br J Cancer 1997;75:1336-9.
14. Garrigue-Antar L, Souza RF, Vellucci VF, et al. Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer. Lab Invest 1996;75:263-72.
15. Barrett MT, Schutte M, Kern SE, et al. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res 1996;56:4351-3.
16. Wu TT, Watanabe T, Heitmiller R, et al. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am J Pathol 1998;153:287-94.
17. Schlemper RJRR, Kato Y, Borchard F, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-5.
18. Ibrahim NBN. Guidelines for handling oesophageal biopsies and resection specimens and their reporting. J Clin Pathol 2000;53:89-94.
19. Palanca-Wessels MC, Klingelhutz A, Reid BJ, et al. Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. Carcinogenesis 2003;24:1183-90.
20. Palanca-Wessels M, Barrett M, Galipeau P, et al. Genetic analysis of long-term Barrett's oesophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. Gastroenterology 1998;114:295-304.
21. Xu G, Chakraborty C, Lala PK. Expression of TGF-beta signaling genes in the normal, premalignant, and malignant human trophoblast: loss of smad3 in choriocarcinoma cells. Biochem Biophys Res Commun 2001;287:47-55.
22. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-6.
23. Yanaihara N, Kohno T, Takakura S, et al. Physical and transcriptional map of a 311-kb segment of chromosome 18q21, a candidate lung tumor suppressor locus. Genomics 2001;72:169-79.
24. Tanaka S, Mori M, Mafune K, et al. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma. Br J Cancer 2000;82:1557-60.
25. Filzgerald RC, Omary MB, Triadafilopoulos G. Acid modulation of HT29 cell growth and differentiation. An in vitro model for Barrett's esophagus. J Cell Sci 1997;110:663-71.
26. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
27. Tang YKV, Srinivasan R, Fogt F, et al. Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis. Cancer Res 2005;65:4228-37.
28. Okano HSH, Miyamoto A, Takaori K, et al. Concomitant overexpression of cyclooxygenase-2 in HER-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome. Clin Cancer Res 2004;10:6938-45.
29. Lazzereschi DNF, Turco A, Ottini L, et al. A complex pattern of mutations and abnormal splicing of Smad4 is present in thyroid tumours. Oncogene 2005;24:5344-54.
30. Xu X, Brodie SG, Yang X, et al. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene 2000;19:1868-74.
31. Jazag AIH, Kanai F, Imamura T, et al. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta. Oncogene 2005;24:662-71.
32. Zhou Y, Kato H, Shan D, et al. Involvement of mutations in the DPC4 promoter in endometrial carcinoma development. Mol Carcinog 1999;25:64-72.
33. Saha D, Datta PK, Beauchamp RD. Oncogenic ras represses transforming growth factor-beta/Smad signaling by degrading tumor suppressor Smad4. J Biol Chem 2001;276:29531-7.
34. Galiana C, Lozano JC, Bancel B, et al. High frequency of Ki-ras amplification and p53 gene mutations in adenocarcinomas or the numan esophagus. Mol Carcinog 1995;14:286-93.
35. Bai RY, Koester C, Ouyang T, et al. SMIF, a Smad4-interacting protein that functions as a co-activator in TGFbeta signalling. Nat Cell Biol 2002;4:181-90.
36. Wan M, Cao X, Wu Y, et al. Jab1 antagonizes TGF-beta signaling by inducing Smad4 degradation. EMBO Rep 2002;3:171-6.
37. Lin X, Liang M, Liang YY, et al. SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J Biol Chem 2003;278:31043-8.
38. Lin X, Liang M, Liang YY, et al. Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4. J Biol Chem 2003;278:18714-9.
39. Lee PS, Chang C, Liu D, et al. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling. J Biol Chem 2003;278:27853-63.
40. Muller N, Reinacher-Schick A, Baldus S, et al. Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells. Oncogene 2002;21:6049-58.
41. Ijichi H, Ikenoue T, Kato N, et al. Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells. Biochem Biophys Res Commun 2001;289:350-7.